Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |